Vanderbilt Heart and Vascular Institute

Vitamin D found to have no impact on blood pressure

Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency.

Study to explore myeloma treatment’s impact on heart

Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart.

Heart patient uses ICD experience to promote benefits of exercise

Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA).

Heart Institute celebrates implantation program success

Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart.

VHVI screening brings heart care to young athletes

Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members.

Churchwell to depart VHVI; Clair to assume interim role

Keith Churchwell, M.D., executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute (VHVI), is departing Vanderbilt and will join Yale-New Haven Health System as vice president and executive director of Cardiovascular Services on Dec. 1.

1 4 5 6 7 8 10